PACB director granted 74,497 stock options
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Christopher Gibson received a grant of stock options covering 74,497 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Christopher Gibson received a grant of stock options covering 74,497 shares of common stock. The options have an exercise price of $1.58 per share and expire on June 3, 2036. They vest monthly over one year, so long as he continues serving as a director through each vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 74,497 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
Key Figures
Key Terms
Stock Option (right to buy) financial
exercise price financial
vesting financial
expiration date financial
derivative securities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PACB director Christopher Gibson report on this Form 4?
What is the exercise price of Christopher Gibson’s PACB stock options?
When do Christopher Gibson’s PACB stock options vest?
When do Christopher Gibson’s PACB stock options expire?
Is Christopher Gibson’s Form 4 transaction a purchase or a grant of PACB stock options?
AI-generated analysis. How Rhea-AI works. Not financial advice.